Currency exchange rates hit Stada's six-month sales

Stada's sales in the first six months of this year were hit by weakened currencies, particularly in Russia, Serbia and the UK, and fell by 8% to €755.2 million. Its earnings before interest, tax, depreciation and amortisation decreased by 16% to €124 million and net profit was down by more than 20% to €48.3 million. Earnings per share reduced from €1.07 in the first half of 2008 to €0.82.

Stada's sales in the first six months of this year were hit by weakened currencies, particularly in Russia, Serbia and the UK, and fell by 8% to €755.2 million. Its earnings before interest, tax, depreciation and amortisation decreased by 16% to €124 million and net profit was down by more than 20% to €48.3 million. Earnings per share reduced from €1.07 in the first half of 2008 to €0.82.

Sales of generic products fell by 4% to €537.8 million, but they still accounted for more than 70% of Stada's...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip